For older women diagnosed with breast cancer, cardiovascular disease (CVD) is a cause of death that is important yet poorly understood, according to a new JAMA Oncology study (2016 Apr 21. [Epub ahead of print]). The study investigators wanted to determine the role that adjuvant endocrine therapies, such as aromatase inhibitors (AIs), might have in CVD in a cohort of postmenopausal breast cancer survivors.
“To this point,” they reported, “no other population-based